4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001498428-25-000003
CEO & President sold 2,640 shares at $13.41 ($35,402)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Cox John · CEO & President
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-09-05 | Sale : show line 1 in the form 10b5-1 | −2,640 | $13.41 | $35,402 | 199,539 | D |
| Open-market sales · 2,640 sh · avg $13.41 · $35,402 | ||||||
Loading xslF345X05/ownership.xml…